**What Is Known**Acute pancreatitis is relatively rare in pediatric group.Acute pancreatitis in children may differ from adult in many aspects, such as epidemiology, etiology, and medical resource use.**What Is New**The incidence of acute pancreatitis by age had 2 peaks. The first peak was at age 4 to 5 years old, and the second one rose from teenagers until adulthood.Girls have longer hospital stays, higher medical expenditures, more use of endoscopic retrograde cholangiopancreatography and biliary tract diseases than boys.The mortality in cases of acute pancreatitis is mostly associated with systemic diseases rather than acute pancreatitis itself.

Acute pancreatitis (AP) refers to the reversible inflammation of the pancreas, starting from injury of acinar cells irrespective of the mechanism. It leads to pancreatic edema, acute inflammatory cell infiltrate, and varying degrees of pancreatic necrosis and hemorrhage ([@R1]--[@R3]). The diagnosis is made by the International Study Group of Pediatric Pancreatitis in search for a cure (INSPPIRE) group with at least 2 of the following: abdominal pain compatible with AP, serum amylase and/or lipase values over 3 times the upper limits of the normal range, and imaging findings consistent with AP ([@R4]). Its etiologies or risk factors include biliary tract diseases, medications, systemic diseases, traumatic events, metabolic disorders, and inborn errors of metabolism. Variable incidences are observed among different age groups related to the above etiologies. For example, inborn error is a major risk factor in children below 2 years old, while a biliary cause is predominant in children over 11 years ([@R1]). In our previous case series study, we found that more than one-third of the cases were due to trauma, followed by structural diseases and systemic diseases ([@R5]).

In recent decades, medical resource use and disease burden have drawn attention in the care of patients with pancreatitis ([@R6]--[@R10]). Shorter lengths of hospital stay and increasing hospitalization charges have been observed in both child and adult AP studies ([@R7],[@R9]). The mortality rate of pediatric AP decreased to less than 5%, which was lower than that for adults ([@R5],[@R11]--[@R13]). Most mortality cases in children were due to underlying systemic diseases, and less than 6% have developed multi-organ dysfunction or pancreatic necrosis ([@R1],[@R12]).

Although some large and population-based studies of adults or whole populations have been published ([@R9],[@R10],[@R14]), current publications of pediatric pancreatitis are limited and are mostly case series ([@R5],[@R13],[@R15]--[@R17]). Since the etiologies or associated risk factors are different between adults and children, it could be difficult to get reliable information from adult experiences. The aims of this study focus on the epidemiology of pediatric AP in Taiwan, pediatric AP patients' hospital stay lengths and medical resource use, and mortality and associated risk factors in pediatric pancreatitis.

METHODS
=======

Data Source and Selection of Cases
----------------------------------

This nationwide population-based study was conducted using the Taiwan National Health Insurance Research Database (NHIRD). The National Health Insurance program is a unique public health and medical insurance system that covered 99.9% of 23 million Taiwanese residents as of the end of 2013. The NHIRD is one of the largest and most comprehensive databases in the world and has been validated and used extensively for epidemiological studies in Taiwan ([@R9],[@R10],[@R14],[@R18]). The NHIRD contains the demographic data of enrollees; service records and expenditure claims from outpatient, inpatient, and ambulatory care; and data associated with contracted pharmacies for reimbursement purposes. Information such as the date of admission, date of discharge, diagnostic codes (up to 5 diagnoses), and procedure codes (up to 5) for all hospital admissions were included. The disease diagnoses used in the NHIRD were coded according to the criteria of the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). This study was reviewed and approved by the Institutional Review Board of the Ditmanson Medical Foundation Chia-Yi Christian Hospital, Taiwan.

We used the diagnostic codes of the ICD-9 to identify patients with primary diagnosis of AP (ICD-9-CM Code 577.0), and patients who were 18 years old or less at the time of admission were included. We only included the inpatient cases and their first hospitalization record in the analysis. Those for whom information on sex or age was missing were excluded. The mortality cases and the associated risk factors were analyzed according to the diagnostic codes (up to 5) of each case and were classified into different disease category. For example, "cholelithiasis" (ICD-9-CM code:574) was classified into biliary tract disease risk factor while "Injury to gastrointestinal tract" (ICD-9-CM code:863) was classified into traumatic risk factor. In addition to providing clinical diagnosis, clinical history of receiving total parenteral nutrition (ICD-9-CM codes: V49.89 and 99.15), abdominal ultrasound (ICD-9-CM code: 88.74, 88.76, and 88.79), abdominal computed tomography examinations (ICD-9-CM code: 793.6, V15.89 and 88.38) or endoscopic retrograde cholangiopancreatography (ICD-9-CM code: V45.89, 51.10, 51.11, 52.13, 52.92, 52.14) were included. Medical resource usage refers to the length of hospital stay and hospital charge. The hospital charge comprised of all the cost of blood work and imaging examinations, procedures, medications, nursing treatment, and ward fee. The examinations and procedures done during hospitalization included abdominal sonogram, abdominal computed tomography, endoscopic retrograde cholangiopancreatography, and others. The costs were converted from Taiwan dollars to US dollars using a currency exchange rate of 30:1.

Statistical Analysis
--------------------

Statistical analysis was performed with SPSS for Windows version 21.0 (IBM Corp, Armonk, NY). Continuous data were presented as the means (± standard deviation, SD) or medians (interquartile range, IQR). Categorical data were presented as numbers and percentages. Descriptive statistics about the distribution of age, gender, LOS, and hospital charges were evaluated by Student\'s *t* test for continuous variables and expressed as the mean ± standard deviation (SD). Categorical variables were analyzed using contingency (cross-tabulation) tables and the chi-square test or Fisher\'s exact test when appropriate. Trends in the prevalence of AP patients were analyzed by Cochrane-Armitage trend tests. *P* \< 0.05 was considered to indicate statistical significance.

RESULTS
=======

Characteristics of the Study Population
---------------------------------------

Between 2000 and 2013, there were 2127 patients admitted to hospitals due to AP, representing a hospitalization rate of 2.83 per 100,000 population. The distributions of selected characteristics between the 1061 girls (49.88%) and 1066 boys (50.11%) are summarized in Table [1](#T1){ref-type="table"}. Age was slightly higher in the boys (*P* = 0.003). Significant differences between girls and boys were found in average LOS, medical costs, receiving endoscopic retrograde cholangiopancreatography (ERCP) procedures, and association with gallstone/biliary tract diseases (*P* \< 0.05).

Incidence of Acute Pancreatitis by Age
--------------------------------------

The incidence of AP reached a peak at age 4 to 5 years in preschool children, and it became stationary in elementary school children (age 7--12 years). After that, the incidence of AP increased steadily with age, up to above 4.0 for girls and 5.0 for boys per 100,000 population. Both genders presented similar trends (Fig. [1](#F1){ref-type="fig"}).
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Incidence of Acute Pancreatitis by Year
---------------------------------------

From 2000 to 2013, the incidence of AP showed a significant increase from 2.33 to 3.07 cases per 100,000 population, with an annual increase of 0.05 cases per 100,000 population. Both genders presented similar trends (see Fig. A, Supplemental Digital Content).

Length of Stay and Medical Expenditure of Hospitalization by Year
-----------------------------------------------------------------

Girls had longer length of stay (LOS) than boys (7 days vs 6 days, *P* \< 0.05). We found that the annual LOS presented a steady rising trend from 2000 to 2007. After reaching a plateau in 2007, the LOS started to decline in both boys and girls (see Fig. B, Supplemental Digital Content). There was, however, a slight rebound in boys in the year 2012--2013. Figure C of the Supplemental Digital Content shows the medical expenditures of AP patients during the period 2000--2013. We have observed an increasing and steady trend of expenditure (*P* for trend \<0.05) with an increase of US\$ 24.58 per year. Girls had a higher medical expenditure than boys. This implies that girls may have more severe clinical courses and longer LOS than boys.

Differences Between Endoscopic Retrograde Cholangiopancreatography and Non-endoscopic Retrograde Cholangiopancreatography Procedure Groups and Factors Associated With In-hospital Mortality
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Seventy-nine patients (3.85%) received the ERCP procedure during the study period. We observed that ERCP was more frequently performed in female patients with AP (69.62% vs 49.12%, *P* \< 0.001), with a ratio of 2.29 (Table [2](#T2){ref-type="table"}). Significant differences were also found in average LOS, hospital levels, and association with gallstone/biliary tract disease as risk factors between ERCP and non-ERCP groups (*P* \< 0.05). We also noticed that average LOS, medical cost, hospital levels, and clinical history of parenteral nutrition administration were significant factors associated with in-hospital mortality (all *P* \< 0.001, Table [3](#T3){ref-type="table"}).

DISCUSSION
==========

This study presents the epidemiology of pediatric pancreatitis in Taiwan and is the first nationwide population-based study in Asian children. The incidence by age had 2 peaks, with the first at age 4 to 5 years old and the second appearing in adolescents. The incidence of AP in Taiwanese children presents a rising trend. The medical cost of AP also increased by years, while the LOS remained stationary during the study period. Girls were noted to have longer LOS and higher medical cost of AP than boys.

During the 14 years of our study period, the incidence of pediatric AP increased from 2.33 to 3.07 cases per 100,000 population (Fig. a, Supplemental Digital Content), similar to the increasing trend noted in Western countries ([@R7]--[@R9],[@R19]--[@R22]), ranging from 3.6 to 13.2 cases per 100,000 children ([@R7],[@R8],[@R19]--[@R22]). Of course, the increase of AP could be due to increased diagnostic awareness ([@R19]). Unfortunately, our dataset did not have the information of specific blood test and we were unable to assess the usage of lipase measurements over the study years. In addition, the advancement of endoscopic and imaging techniques may make the diagnosis of AP more feasible and prompt ([@R23]--[@R25]). Furthermore, the advance of genetic testing and molecular techniques may also help in revealing the etiology of the previous "idiopathic" cases ([@R26],[@R27]). At the same time, the associated risk factors or comorbidities are also simultaneously increasing. For example, the prevalence of obesity and incidence of inflammatory bowel disease in Taiwan increased in the same period ([@R28]--[@R31]).

In addition, the incidence of pediatric AP in Taiwan had 2 peaks by age (Fig. [1](#F1){ref-type="fig"}). The incidence increased with age since birth, reached the first peak at age 4 to 5 years old and became stationary in elementary school children (age 7--12 years). Then, the incidence increased again in adolescents, which is similar to findings in other pediatric studies ([@R7],[@R8]). We suggest that the first peak is due to some congenital causes that are gradually discovered after birth. In contrast, the second peak could be mainly attributed to acquired cases, such as gallstones and biliary diseases, which have been mentioned in several studies ([@R1],[@R7],[@R8],[@R12]). Furthermore, the increasing prevalence of obesity in adolescence in recent years also results in the increasing risk of dyslipidemia or gallstone diseases ([@R30],[@R31]), further contributing to the rising trend of AP.

The annual LOS presented a steady trend, but the medical cost of hospitalization increased gradually during the study period. These findings are different from previous studies in Western countries in which the LOS decreased during their study period ([@R6],[@R8]). This could be explained by different cultural and national conditions between Asian and Western countries. For example, hospitalization fees are generally relatively higher in Western countries. Furthermore, younger children had longer hospital stays and higher medical costs, which was in line with a previous study ([@R32]). More difficulty in diagnosis and a longer transition to oral feeding in pediatric patients may result in the longer LOS.

Although female predominance was observed in previous studies ([@R5],[@R7]), the incidence of AP was not different between the 2 genders in our study. We, however, found that girls had longer LOS and higher medical cost than boys. Menarche, pregnancy, obesity, and the use of oral contraceptives are common risk factors of cholelithiasis ([@R33]), which could make girls more susceptible to gallstone disease. That is why there is a significantly higher proportion of girls receiving ERCP procedures (Table [2](#T2){ref-type="table"}). Underlying conditions and the performance of ERCP procedures both lead to the longer hospital stay and higher medical cost in girls. A recent study stated that the children with choledocholithiasis underwent ERCP before cholecystectomy may have longer LOS if not having available ERCP proceduralists ([@R34]). Similar situation was also noted in Taiwan, and it further supports our argument. In this study, we found that in-hospital mortality rate of AP ranged from 0.35% to 4.2% in the last 14 years (Table [3](#T3){ref-type="table"}), without a significant trend or gender difference. The most common risk factor or comorbidity was systemic disease, which was consistent with previous studies ([@R5],[@R11]--[@R13]).

There are some limitations in our study. First, this is a retrospective secondary data analysis study, and all data were from the Taiwan National Health Insurance Research Database. The AP in this study was defined by the International Classification of Diseases, Ninth Revision codes rather than by clinical, laboratory and radiological findings. There may be some bias due to coding error or inconsistent diagnosis of AP by the institutions and clinicians. Second, unlike other studies using single institute data, the lack of pharmacy data and chart review of our study made it difficult to clarify the true etiology of each case. In addition, as we only focused on the first episode of AP cases, without their following information, we are unable to tell whether the "risk factors" were pre-existing conditions or something that developed at the onset of the pancreatitis. Similar limitations have been described in other database research ([@R8]). Therefore, our study favors using the term "risk factor" or "comorbidity" rather than "etiology" in the analysis.

CONCLUSIONS
===========

This study presents the epidemiology of pediatric pancreatitis in Taiwan and is the first nationwide population-based study in Asian children. The incidence of pediatric AP in Taiwan is rising. The average hospital stay is steady, but the medical cost of AP has been increasing during the past decade. There is a gender difference in that girls have longer hospital stays and higher medical expenditures than boys. The mortality in cases of AP is mostly associated with systemic diseases rather than AP itself. Further studies are needed to better clarify the etiologies and associated risk factors of AP in children.
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Characteristics of Acute Pancreatitis in Children Aged \<18 Years, National Health Insurance Claims Database of Taiwan, 2000--2013

                             Total (N = 2127)   Female (N = 1061)   Male (N = 1066)   *P*
  -------------------------- ------------------ ------------------- ----------------- ----------
  Age, y                     11.91 ± 5.38       11.55 ± 5.45        12.25 ± 5.29      0.003
  Length of stay, days       6 (3--14)          7 (4--15)           6 (3--13)         \<0.001
  Medical cost (USD)         711 (322--2955)    857 (346--3683)     640 (300--2053)   \<0.001
  Level of hospital                                                                   
   Medical center            954 (44.85)        499 (47.03)         455 (42.68)       0.127
   Regional hospital         839 (39.45)        400 (37.70)         439 (41.18)       
   District hospital         334 (15.70)        162 (15.27)         172 (16.14)       
  Procedure                                                                           
   Parental nutrition        51 (2.40)          30 (2.83)           21 (1.97)         0.196
   Abdomen ultrasound        303 (14.25)        156 (14.70)         147 (13.79)       0.547
   CT scan of abdomen        13 (0.61)          7 (0.66)            6 (0.56)          0.774
   ERCP                      79 (3.71)          55 (5.18)           24 (2.25)         \< 0.001
  Risk factors                                                                        
   Biliary/anatomy disease   642 (29.57)        365 (33.12)         277 (25.91)       \< 0.001
   Metabolic                 463 (21.77)        246 (23.19)         217 (20.36)       0.114
   Trauma                    120 (5.64)         50 (4.71)           70 (6.57)         0.064
   Infection                 694 (32.63)        344 (32.42)         350 (32.74)       0.840
   Hematology/oncology       171 (8.04)         83 (7.82)           88 (8.26)         0.714
   Systemic disease          741 (34.84)        373 (35.16)         368 (34.52)       0.759
  In-hospital death          35 (1.65)          16 (1.51)           19 (1.78)         0.619

CT = computed tomography; ERCP = endoscopic retrograde cholangiopancreatography.

###### 

Children With Endoscopic Retrograde Cholangiopancreatography

                             Non-ERCP (N = 2048)   ERCP (N = 79)       *P*
  -------------------------- --------------------- ------------------- ---------
  Sex                                                                  
   Female                    1006 (49.12)          55 (69.62)          \<0.001
   Male                      1042 (50.88)          24 (30.38)          
  Age, y                     11.92 ± 5.34          11.47 ± 6.17        0.463
  Length of stay, days       6 (3--14)             12 (8--18)          \<0.001
  Medical cost (USD)         674 (315--2601)       3585 (1892--5277)   
  Level of hospital                                                    
   Medical center            896 (43.75)           58 (73.42)          \<0.001
   Regional hospital         819 (39.99)           20 (25.32)          
   District hospital         333 (16.26)           1 (1.27)            
  Procedure                                                            
   Parental nutrition        47 (2.29)             4 (5.06)            0.118
   Abdomen ultrasound        295 (14.40)           8 (10.13)           0.286
   CT scan of abdomen        13 (0.63)             0 (0.00)            1.000
  Risk factors                                                         
   Biliary/anatomy disease   572 (27.93)           70 (88.61)          \<0.001
   Systemic disease          728 (35.55)           13 (16.46)          \<0.001
   Hematology/oncology       166 (8.11)            5 (6.33)            0.569
   Trauma                    117 (7.91)            3 (3.80)            0.759
   Metabolic                 460 (22.45)           3 (3.80)            \<0.001
   Infection                 692 (33.79)           2 (2.53)            \<0.001
  In-hospital death          34 (1.66)             1 (1.27)            1.0000

CT = computed tomography, ERCP = endoscopic retrograde cholangiopancreatography.

###### 

In-hospital Mortality

                             Survival (N = 2092)   In-hospital Death (N = 35)   *P*
  -------------------------- --------------------- ---------------------------- ----------
  Sex                                                                           
   Female                    1045 (49.95)          16 (45.71)                   0.619
   Male                      1047 (50.05)          19 (54.29)                   
  Age, y                     11.90 ± 5.37          12.23 ± 5.60                 0.712
  Length of stay, days       6 (3--14)             23 (5--43)                   \<0.001
  Medical cost (USD)         693 (318--2734)       16058 (5759--30089)          \<0.001
  Hospital level                                                                
   Medical center            923 (44.12)           31 (88.57)                   \<0.001
   Regional hospital         836 (39.96)           3 (8.57)                     
   District hospital         333 (15.92)           1 (2.86)                     
  Procedure                                                                     
   Parental nutrition        46 (2.20)             5 (14.29)                    \<0.0001
   Abdomen ultrasound        300 (14.34)           3 (8.57)                     0.333
   CT scan of abdomen        13 (0.62)             0 (0.00)                     1.000
   ERCP                      78 (3.73)             1 (2.86)                     1.000
  Risk factors                                                                  
   Systemic disease          710 (33.94)           31 (88.57)                   \<0.001
   Infection                 682 (32.60)           12 (34.29)                   0.833
   Hematology/oncology       163 (7.79)            8 (22.86)                    \<0.001
   Biliary/anatomy disease   637 (30.45)           5 (14.29)                    0.039
   Metabolic                 460 (21.99)           3 (8.57)                     0.123
   Trauma                    119 (5.69)            1 (2.86)                     0.520

CT = computed tomography, ERCP = endoscopic retrograde cholangiopancreatography.
